Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 10/20 | 0.40 |
| ▸ | ACHE | P22303 | 7/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL4881196 | 0.84 | KDM4E (0.47) | KCNH2ACHEGPR3KDM4EALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL4497025 | 0.83 | KCNH2 (0.41) | KCNH2ACHEGPR3KDM4EALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL31472680 | 0.83 | KCNH2 (0.41) | KCNH2ACHEGPR3KDM4EALDH1A1 | |
| SCHEMBL4622504 | 0.83 | ACHE (0.50) | ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL3855070 | 0.82 | KCNH2 (0.43) | KCNH2ACHEGPR3 | |
| Fluoride Ion SCHEMBL4495682 | 0.81 | ACHE (0.49) | ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL6554225 | 0.81 | ACHE (0.46) | KCNH2ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL11070399 | 0.81 | KCNH2 (0.38) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL5948989 | 0.78 | KCNH2 (0.51) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL7077338 | 0.78 | GPR3 (0.41) | KCNH2ACHEGPR3KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090234151-A1 | Preparation of Mono-/Difluorinated Hydrocarbon Compounds | RHODIA CHIMIE (FR) | 2009-09-17 | — | — | US | claimed |
| US-20090234151-A1 | Preparation of Mono-/Difluorinated Hydrocarbon Compounds | RHODIA CHIMIE (FR) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090234151-A1 | Preparation of Mono-/Difluorinated Hydrocarbon Compounds | AHR, CYP2E1, CYP2F1 | KCNH2 890/4885ACHE 3533/4885GPR3 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.